While c-MYC is known to induce the expression of glycolytic genes and LDHA in several tumor types, neither an enrichment of glycolytic signatures nor increased lactate levels were observed in MYC-transformed ventral prostate compared to wild-type prostate, suggesting tumor/context-specific MYC-driven metabolic vulnerabilities [61]. Here, LDHA is linked to neoplasm.